Experimental Duchenne Muscular Dystrophy Treatment Earns Rare Pediatric Disease Designation
source: pixabay.com

Experimental Duchenne Muscular Dystrophy Treatment Earns Rare Pediatric Disease Designation

According to a story from apnews.com, the biopharmaceutical company FibroGen, Inc., has recently announced that its investigational treatment pamrevlumab has earned Rare Pediatric Disease designation from the US Food and…

Continue Reading Experimental Duchenne Muscular Dystrophy Treatment Earns Rare Pediatric Disease Designation

Light Therapy: A Safe, Effective, and Low-Cost Approach to Some Neurodegenerative Diseases

In the last decade, scientists have made great strides in uncovering details of the underlying causes of neurodegenerative diseases. It is only a matter of time that treatment and prevention…

Continue Reading Light Therapy: A Safe, Effective, and Low-Cost Approach to Some Neurodegenerative Diseases